CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 2, March 2012
96
AFRICA
the patients presenting with cardiac symptoms in our hospital.
Hypertensive heart disease may become an important cause of
cardiac involvement in the future. Large prospective studies are
needed in order to confirm this observation.
References
1.
Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA,
Beschorner WE,
et al.
Myocarditis and cardiotropic viral infection
associated with severe left ventricular dysfunction in late-stage infec-
tion with human immunodeficiency virus.
J Am Coll Cardiol
1994;
24
(4): 1025–1032.
2.
Lewis W. AIDS: cardiac findings from 115 autopsies.
Prog Cardiovasc
Dis
1989;
32
(3): 207–215.
3.
Boccara F. Cardiovascular complications and atherosclerotic manifesta-
tions in the HIV-infected population: type, incidence and associated risk
factors.
Aids
2008;
22
(3): S19–26.
4.
Cegielski JP, Lwakatare J, Dukes CS, Lema LE, Lallinger GJ, Kitinya
J,
et al.
Tuberculous pericarditis in Tanzanian patients with and without
HIV infection.
Tuber Lung Dis
1994;
75
(6): 429–434.
5.
Hakim JG, Matenga JA, Siziya S. Myocardial dysfunction in human
immunodeficiency virus infection: an echocardiographic study of 157
patients in hospital in Zimbabwe.
Heart
1996;
76
(2): 161–165.
6.
Longo-Mbenza B, Tonduangu K, Muvova D, Phuati MB, Seghers
KV, Kestelot H. [A clinical study of cardiac manifestations related to
acquired immunodeficiency syndrome (AIDS) in Kinsaha].
Arch Mal
Coeur Vaiss
1995;
88
(10): 1437–1443.
7.
Seaberg EC, Munoz A, Lu M, Detels R, Margolick JB, Riddler SA,
et
al.
Association between highly active antiretroviral therapy and hyper-
tension in a large cohort of men followed from 1984 to 2003.
Aids
2005;
19
(9): 953–960.
8.
Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P, Sacchi P,
et al
. Hypertension among HIV patients: prevalence and relationships
to insulin resistance and metabolic syndrome.
J Hypertens
2003;
21
(7):
1377–1382.
9.
Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara
F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected
African patients not receiving HAART: a multicenter, observational,
prospective, cohort study in Rwanda.
Curr HIV Res
2007;
5
(1):
129–137.
10. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people
living in Africa: a review.
Cardiovasc J S Afr
2003;
14
(5): 231–237.
11. Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial
disease and human immunodeficiency virus in Dar es Salaam,
Tanzania.
Lancet
1990;
335
(8683): 209–212.
12. Fleiss JL.
Statistical Methods for Rates and Proportions
. Oxford: John
Wiley & Sons, 1973: formulae 3.18, 3.19.
13. Nzuobontane D, Blackett KN, Kuaban C. Cardiac involvement in HIV
infected people in Yaounde, Cameroon.
Postgrad Med J
2002;
78
(925):
678–681.
14. Nutritional anaemias. Report of a WHO scientific group.
World Health
Organ Tech Rep Ser
1968;
405
: 5–37.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E,
Pellikka PA,
et al
. Recommendations for chamber quantification.
Eur J
Echocardiogr
2006;
7
(2): 79–108.
16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs
I, et al. Echocardiographic assessment of left ventricular hypertrophy:
comparison to necropsy findings.
Am J Cardiol
1986;
57
(6): 450–458.
17. de Simone G, Devereux RB, Maggioni AP, Gorini M, de Divitiis O,
Verdecchia P. Different normalizations for body size and population
attributable risk of left ventricular hypertrophy: the MAVI study.
Am J
Hypertens
2005;
18
(10): 1288–1293.
18. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation
of arterial structure and function to left ventricular geometric patterns in
hypertensive adults.
J Am Coll Cardiol
1996;
28
(3): 751–756.
19. How to diagnose diastolic heart failure. European Study Group on
Diastolic Heart Failure.
Eur Heart J
1998;
19
(7): 990–1003.
20. Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H,
Schiller NB,
et al.
Pericardial effusion in AIDS. Incidence and survival.
Circulation
1995;
92
(11): 3229–3234.
21. Shepard C, Alexander S, Burstein S. Effusions of body cavity fluids
in patients with the acquired immunodeficiency syndrome or human
immunodeficiency virus infection.
Acta Cytol
1991;
35
: 632–633.
22. Longo-Mbenza B, Tonduangu K, Seghers KV, Mubagwa D. [HIV infec-
tion and pericardial disease invasion in Africa].
Arch Mal Coeur Vaiss
1997;
90
(10): 1377–1384.
23. Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F,
Maartens G,
et al.
Clinical characteristics and initial management of
patients with tuberculous pericarditis in the HIV era: the Investigation
of the Management of Pericarditis in Africa (IMPI Africa) registry.
BMC Infect Dis
2006;
6
: 2.
24. ChenY, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human
immunodeficiency virus-associated pericardial effusion: report of 40
cases and review of the literature.
Am Heart J
1999;
137
(3): 516–521.
25. Reynolds MM, Hecht SR, Berger M, Kolokathis A, Horowitz SF. Large
pericardial effusions in the acquired immunodeficiency syndrome.
Chest
1992;
102
(6): 1746–1747.
26. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact
of highly active antiretroviral therapy in HIV-positive patients with
cardiac involvement.
J Infect
2000;
40
(3): 282–284.
27. Aoun S, Ramos E. Hypertension in the HIV-infected patient.
Curr
Hypertens Rep
2000;
2
(5): 478–481.
28. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N,
et al. Metabolic abnormalities and cardiovascular disease risk factors in
adults with human immunodeficiency virus infection and lipodystro-
phy.
Clin Infect Dis
2001;
32
(1): 130–139.
29. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN.
Prevalence of hypertension in HIV-positive patients on highly active
retroviral therapy (HAART) compared with HAART-naive and
HIV-negative controls: results from a Norwegian study of 721 patients.
Eur J Clin Microbiol Infect Dis
2003;
22
(12): 731–736.
30. Jerico C, Knobel H, Montero M, Sorli ML, Guelar A, Gimeno JL,
et al
.
Hypertension in HIV-infected patients: prevalence and related factors.
Am J Hypertens
2005;
18
(11): 1396–1401.
31. Barbarinia G, Barbaro G. Incidence of the involvement of the cardio-
vascular system in HIV infection.
Aids
2003;
17
(1): S46–50.
32. Niakara A, Drabo YJ, Kambire Y, Nebie LV, Kabore NJ, Simon F.
[Cardiovascular diseases and HIV infection: study of 79 cases at the
National Hospital of Ouagadougou (Burkina Faso)].
Bull Soc Pathol
Exot
2002;
95
(1): 23–26.
33. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodefi-
ciency virus infection and pulmonary hypertension: two new cases and
a review of 86 reported cases.
Mayo Clin Proc
1998;
73
(1): 37–45.
34. Le Houssine P, Karmochkine M, Ledru F, Batisse D, Piketty C,
Kazatchkine MD, et al. [Primary pulmonary hypertension in human
immunodeficiency virus infection. Study of 9 cases amd review of the
literature].
Rev Med Interne
2001;
22
(12): 1196–1203.
35. Barbaro G. Cardiovascular manifestations of HIV infection.
Circulation
2002;
106
(11): 1420–1425.
36. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA.
Heart muscle disease related to HIV infection: prognostic implications.
Br Med J
1994;
309
(6969): 1605–1607.
37. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of
dilated cardiomyopathy and detection of HIV in myocardial cells of
HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei
Pazienti Affetti da AIDS.
N Engl J Med
1998;
339
(16): 1093–1099.
38. Watkins DA, Mayosi BM. The contribution of South Africans to the
subject of dilated cardiomyopathy. With reference to: Cardiovascular
collagenosis with parietal endocardial thrombosis. A clinicopathologic
study of forty cases.
Cardiovasc J Afr
2009;
20
(1): 11–16.
39. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller
MJ. Incidence and prognostic value of malnutrition and wasting in
human immunodeficiency virus-infected outpatients.
J Acquir Immune
Defic Syndr Hum Retrovirol
1995;
8
(3): 239–246.
40. Dworkin BM, Antonecchia PP, Smith F, Weiss L, Davidian M, Rubin D,
et al.
Reduced cardiac selenium content in the acquired immunodefi-
ciency syndrome. JPEN
J Parenter Enteral Nutr
1989;
13
(6): 644–647.
